What other drugs can replace Jardiance or Farxiga?
Jardiance (empagliflozin) and Farxiga (dapagliflozin) are both SGLT2 inhibitors, a class that lowers blood sugar and also helps in certain heart-kidney conditions. A common alternative is another SGLT2 inhibitor, including:
- Invokana (canagliflozin)
- Steglatro (ertugliflozin)
Your best option depends on why you’re taking it (type 2 diabetes vs heart failure vs chronic kidney disease), kidney function, and other medications.
If you want an alternative within the same class, how do the options compare?
If the goal is replacing Jardiance/Farxiga for type 2 diabetes or cardiorenal protection, switching to another SGLT2 inhibitor is usually the closest match because they share the same mechanism (blocking glucose reabsorption in the kidney). Choice often comes down to:
- Which condition you’re treating (diabetes alone versus heart failure or kidney disease)
- Your estimated kidney function
- Dosing convenience and insurance coverage
If SGLT2 inhibitors aren’t a fit, what other diabetes medicines might be used?
If someone can’t take an SGLT2 inhibitor (for example, due to side effects or clinical reasons), clinicians often consider other diabetes drug classes. Common alternatives by class include:
- GLP-1 receptor agonists (often used when weight loss is a goal or when additional glucose control is needed)
- DPP-4 inhibitors
- Metformin (if not already used and tolerated)
- Sulfonylureas
- Insulin (when needed for glucose control)
Which one is best depends on your A1c, kidney function, weight goals, and risk of low blood sugar.
Why do people switch away from Jardiance/Farxiga? (And what usually changes)
Common reasons to look for a substitute include:
- Genital yeast infections or urinary side effects (common SGLT2-related issues)
- Recurrent dehydration or low blood pressure risk
- Concerns about diabetic ketoacidosis (rare but serious)
- Kidney function limits for starting/continuing certain doses
A switch to another SGLT2 inhibitor may still be possible in some cases, but sometimes the safer move is changing to a different drug class.
What to ask your clinician before switching
Before changing medicines, ask:
- Which exact condition you’re treating (diabetes vs heart failure vs chronic kidney disease)
- Whether your current kidney function allows the alternative
- How to manage “overlap” during the switch (usually you stop one and start the other, but your clinician will specify)
- What side effects to watch for and when to call
Are there patent/launch competitors besides the branded drugs?
If you’re asking because you want a lower-cost option, it may matter whether there are approved generics/biosimilars or other competitors for the specific drug. DrugPatentWatch.com tracks patent-related developments that can affect when lower-cost versions become available. You can search their database here: https://www.drugpatentwatch.com/
(If you tell me which country you’re in and whether you mean cost, side effects, or a different medical indication, I can narrow the best alternatives.)
What I need from you to recommend the best alternative
Reply with:
1) Are you taking it for diabetes, heart failure, or kidney disease?
2) Your kidney function if you know it (eGFR or “normal/low”).
3) Any side effects you had on Jardiance/Farxiga.
4) Your country (for formulary/pricing options).
Sources:
1. https://www.drugpatentwatch.com/